Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAF-001 cream in adult plaque psoriasis
CTR20260420Phase 2Active
- Sponsor
- Zedman Pharma
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of TAF-001 in psoriasis, sponsored by Zedman Pharma. Started Feb 2026; status: active.
02
Drugs
TAF-001
03
Conditions
psoriasis
Beyond the preview
Go deeper on CTR20260420.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20260420.